A Study of EP0031 (Lunbotinib) in Patients With Advanced RET-altered Malignancies
Clinical trial NCT05443126 · RECRUITING
Trial details
- NCT number
- NCT05443126
- Sponsor
- Ellipses Pharma
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-09-30
- Primary completion
- 2027-03-01
- Enrollment
- 265
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.